XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Financial Instruments
9 Months Ended
Oct. 03, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

9. Derivative Financial Instruments

The Company entered into an interest rate swap agreement in December 2017 to manage its cash flow associated with variable interest rates. This forward contract has been designated and qualifies as a cash flow hedge, and its change in fair value is recorded as a component of other comprehensive income and reclassified into earnings in the same period or periods in which the forecasted transaction occurs. The forward contract initially consisted of five cash flow hedges, of which two were outstanding at October 3, 2021. To qualify as a hedge, the Company needs to formally document, designate and assess the effectiveness of the transactions that receive hedge accounting.

The notional dollar amount of the two outstanding swaps was $250.0 million at October 3, 2021 and January 3, 2021, under which the Company pays a fixed rate and receives a variable rate of interest (cash flow swap). The cash flow swaps hedge the change in interest rates on debt related to fluctuations in interest rates and each have a length of one year and mature annually from 2021 to 2022. These interest rate swaps have been designated and qualify as cash flow hedges and have met the requirements to assume zero ineffectiveness. The Company reviews the effectiveness of its hedging instruments on a quarterly basis.

The counterparties to these derivative financial instruments are major financial institutions. The Company evaluates the credit ratings of the financial institutions and believes that credit risk is at an acceptable level. The following table summarizes the fair value of the Company’s derivative instruments designated as hedging instruments:

 

 

 

As of
October 3, 2021

 

 

As of
January 3, 2021

 

 

 

Balance Sheet Location

 

Fair Value

 

 

Balance Sheet Location

 

Fair Value

 

Interest rate swaps

 

Accrued liabilities

 

$

1,479

 

 

Accrued liabilities

 

$

5,695

 

Interest rate swaps

 

Other long-term liabilities

 

 

5,802

 

 

Other long-term liabilities

 

 

5,756

 

 

The gain or loss on these derivative instruments is recognized in other comprehensive income, net of tax, with the portion related to current period interest payments reclassified to interest expense, net on the consolidated statements of income. The following table summarizes these losses classified on the consolidated statements of income:

 

 

 

Thirteen weeks ended

 

 

Thirty-nine weeks ended

 

 

 

October 3, 2021

 

 

September 27, 2020

 

 

October 3, 2021

 

 

September 27, 2020

 

Consolidated Statements of
   Income Classification

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

$

1,448

 

 

$

1,345

 

 

$

4,328

 

 

$

2,855